Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bryskier

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Pathologie-Biologie|May 1, 1985
[Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis]J P Stahl, J Croize, J P Bru, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenesK Nagai, T A Davies, L M Ednie, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 10, 2001
Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, GermanyC M Brandt, M Honscha, N D Truong, et al.
International Journal of Antimicrobial Agents|June 9, 2001
Classification of oral cephalosporins. A matter for debateJ D Williams, K G Naber, A Bryskier, et al.
Pathologie-Biologie|May 1, 1983
[Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers]A Bryskier, G Humbert, F Borsa, et al.
Pathologie-Biologie|June 1, 1986
[Pharmacokinetics of ofloxacin in the elderly (65-85 years) with normal renal function after a single oral dose of 200 mg]P Veyssier, J B Fourtillan, J Modai, et al.
Pathologie-Biologie|June 1, 1984
[Bacteriologic, clinical and kinetic evaluation of cefmenoxime (SCE 1365) in the treatment of 68 cases of septicemia. A multicenter trial]A Bryskier, J P Sollet, G Bleichner, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Pathologie-Biologie|May 1, 1985
[Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis]J P Stahl, J Croize, J P Bru, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenesK Nagai, T A Davies, L M Ednie, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 10, 2001
Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, GermanyC M Brandt, M Honscha, N D Truong, et al.
International Journal of Antimicrobial Agents|June 9, 2001
Classification of oral cephalosporins. A matter for debateJ D Williams, K G Naber, A Bryskier, et al.
Pathologie-Biologie|May 1, 1983
[Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers]A Bryskier, G Humbert, F Borsa, et al.
Pathologie-Biologie|June 1, 1986
[Pharmacokinetics of ofloxacin in the elderly (65-85 years) with normal renal function after a single oral dose of 200 mg]P Veyssier, J B Fourtillan, J Modai, et al.
Pathologie-Biologie|June 1, 1984
[Bacteriologic, clinical and kinetic evaluation of cefmenoxime (SCE 1365) in the treatment of 68 cases of septicemia. A multicenter trial]A Bryskier, J P Sollet, G Bleichner, et al.
Pageof 11